Ligand validation:6NH8

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NH8_BTB_C_504	82%	76%	0.113	0.967	0.38	0.57	-	-	4	0	100%	1
6NH8_BTB_A_504	56%	74%	0.118	0.889	0.36	0.64	-	-	3	0	100%	1
6NH8_BTB_A_505	51%	80%	0.126	0.88	0.39	0.44	-	-	8	0	100%	1
6NH8_BTB_B_505	45%	64%	0.134	0.866	0.47	0.89	-	-	7	0	100%	1
6NH8_BTB_D_505	38%	70%	0.143	0.843	0.41	0.74	-	-	5	0	100%	1
6NH8_BTB_C_506	37%	89%	0.115	0.809	0.36	0.29	-	-	4	0	100%	1
6NH8_BTB_B_504	34%	69%	0.144	0.826	0.42	0.78	-	-	2	0	100%	1
6NH8_BTB_C_505	22%	59%	0.2	0.812	0.66	0.89	-	-	2	0	100%	1
6NH8_BTB_B_506	18%	82%	0.2	0.789	0.34	0.46	-	-	4	0	100%	1
6NH8_BTB_A_506	7%	84%	0.208	0.665	0.34	0.42	-	-	4	0	100%	1
6NH8_BTB_D_504	5%	68%	0.205	0.6	0.39	0.85	-	-	5	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.